The firms will combine Caris' multimodal genomic data with Ontada's community oncology-based real-world data to support cancer drug development.

GeneDx Corp's 2024 success story: profitability, 100x returns, NICU market expansion, pediatric neurology diagnostics, and ...

The company will be the first to integrate whole genome sequencing (WGS) into Epic's Aura platform, further advancing access ...

Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that the company expects to report revenue of $713 million for the fourth quarter ...

The study provides a valuable analysis of escape from X-inactivation based on three rare female GTEX-donors with non-mosaic X-inactivation. The methods and analyses broadly support the author's claims ...

The "Whole Genome and Exome Sequencing Market: By Application, Organism and Product with Executive and Consultant Guid ...

Shares of the IBD 50's GeneDx surged Monday after the Food and Drug Administration issued guidance about using AI to develop medical devices.

NEW YORK – After two years of decline in 2022 and 2023, the 360Dx Top 30 rebounded in 2024, rising 4 percent year over year.

Commissions do not affect our editors' opinions or evaluations. State Farm is the best whole life insurance company, according to our analysis. We evaluated about 3,000 whole life insurance ...

If the term life insurance isn't covering you adequately, you may want to consider a whole life policy, often referred to as permanent life insurance. You'll have to jump through more hoops to ...